Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Eur J Oral Sci. 2011 Dec;119(Suppl 1):8–12. doi: 10.1111/j.1600-0722.2011.00868.x

Table 3.

Dental fluorosis assessment

Strain Fluoride treatment
0 ppm F− 50 ppm F−
Clinical* QF** Clinical QF
Male
Accn1 KO (n = 6) 0.0 ± 0.0 13.95 ± 1.21 3.19 ± 0.9 24.04 ± 5.23
Wildtype $(n = 9) 0.6 ± 0.6 15.44 ± 2.25 3.28 ± 0.4 23.70 ± 4.66
p = 0.029 p = 0.164 p = 0.790 p = 0.888
Female
Accn1 KO (n = 5) 0.2 ± 0.4 13.60 ± 1.16 3.00 ± 0.9 25.12 ± 4.67
Wildtype (n = 8) 0.1 ± 0.3 14.88 ± 4.25 3.13 ± 0.5 21.07 ± 5.15
p = 0.841 p = 0.491 p = 0.760 p = 0.181
Combined
Accn1 KO (n = 11) 0.1 ± 0.3 13.77 ± 1.14 3.1 ± 0.9 24.45 ± 4.85
Wildtype (n = 17) 0.4 ± 0.6 15.17 ± 3.24 3.2 ± 0.5 22.46 ± 4.93
p = 0.095 p = 0.164 p = 0.717 p = 0.278
*

Modified TF scale

**

Quantitative fluorescence

$

C57BL/6J inbred strain